Who owns EyePoint Pharmaceuticals, Inc.?
Institutional ownership of EYPT from SEC Form 13F filings across 138 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
138
13F holders
$882.6M
value, 2026 filers
74%
of shares outstanding (62.0M sh)
22
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of EYPT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | MONTANOVA CAPITAL, LLC | 8.3M | $118.6M | 2.2% | 9.9% | 0.0% |
| 2 | BlackRock, Inc. | 7.5M | $106.7M | 0.0% | 8.9% | +4.0% |
| 3 | FEDERATED HERMES, INC. | 5.7M | $81.2M | 0.1% | 6.8% | +0.2% |
| 4 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 4.8M | $69.0M | 0.1% | 5.8% | +46.3% |
| 5 | FRANKLIN RESOURCES INC | 4.8M | $68.7M | 0.0% | 5.7% | -4.8% |
| 6 | Jupiter Topco LLCNEW | 3.8M | $53.9M | 0.0% | 4.5% | new |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 3.6M | $51.9M | 0.0% | 4.3% | -49.0% |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 2.1M | $29.5M | 0.0% | 2.5% | +4.0% |
| 9 | Aberdeen Group plc | 2.0M | $28.7M | 0.0% | 2.4% | +15.6% |
| 10 | CITADEL ADVISORS LLC | 2.0M | $28.3M | 0.0% | 2.4% | +3.8% |
| 11 | Balyasny Asset Management L.P. | 1.8M | $25.9M | 0.0% | 2.2% | +26.0% |
| 12 | TWO SIGMA INVESTMENTS, LP | 1.2M | $16.9M | 0.0% | 1.4% | +174.5% |
| 13 | VANGUARD PORTFOLIO MANAGEMENT LLC | 971,014 | $13.9M | 0.0% | 1.2% | +22.3% |
| 14 | AMERIPRISE FINANCIAL INC | 848,410 | $12.1M | 0.0% | 1% | +100.4% |
| 15 | HSBC HOLDINGS PLC | 833,455 | $11.9M | 0.0% | 1% | 0.0% |
| 16 | Candriam S.C.A. | 787,769 | $11.3M | 0.1% | 0.9% | +16.8% |
| 17 | Blue Owl Capital Holdings LP | 762,594 | $10.9M | 1.6% | 0.9% | -16.4% |
| 18 | NORTHERN TRUST CORP | 720,917 | $10.3M | 0.0% | 0.9% | +6.5% |
| 19 | Sixth Street Partners Management Company, L.P.NEW | 647,613 | $9.3M | 1.6% | 0.8% | new |
| 20 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 647,613 | $9.3M | 0.0% | 0.8% | +1.2% |
| 21 | VANGUARD FIDUCIARY TRUST CO | 559,216 | $8.0M | 0.0% | 0.7% | +10.9% |
| 22 | MILLENNIUM MANAGEMENT LLC | 500,093 | $7.2M | 0.0% | 0.6% | +5.2% |
| 23 | GOLDMAN SACHS GROUP INC | 465,087 | $6.7M | 0.0% | 0.6% | -33.5% |
| 24 | Ghisallo Capital Management LLCNEW | 350,000 | $5.0M | 0.1% | 0.4% | new |
| 25 | MORGAN STANLEY | 336,730 | $4.8M | 0.0% | 0.4% | -69.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.